Q
Q32 Bio
1 follower
Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.
Org chart
Jodie Morrison
Acting CEO
Collapse
Shelia Violette
Co-Founder & Chief Scientific Officer
Jason Campagna
Chief Medical Officer
David Appugliese
SVP & Head of People
Maria Marzilli
EVP, Corporate Strategy & Program Operations
Bill Lundberg
Independent Director
Fei Liu
Director, Pharmacology
Hong Wu, MD, PhD, DABT
Senior Vice President, Head Of Development At Q32 Bio
Isidora Tošić
New Product Planning Manager
Theresa Carbeau
Director, CMC
Board & advisors
Mark Iwicki
Director
Bill Lundberg
Director
Isaac Manke
Director
Diyong Xu
Director
David Grayzel
Director
Kathy LaPorte
Director
John P. Atkinson
Scientific Advisor
Michael Holers
Scientific Advisor
Brian Kotzin
Scientific Advisor
Simon Read
Scientific Advisor
Jayson Punwani
Director